NEOGENOMICS INC (NEO) Stock Cash Flow
NASDAQ:NEO - Nasdaq - US64049M2098 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -77.59M | -78.73M | -87.97M | -144.25M | -8.35M | |||
| Depreciation Amortization | 72.01M | 72.55M | 72.58M | 69.43M | 53.35M | |||
| Change In Working Capital | -34.76M | -32.63M | -25.49M | -31.70M | -4.99M | |||
| Interest Paid | 3.40M | 3.83M | 3.38M | 3.40M | 3.07M | |||
| Taxes Paid | 118.00K | 207.00K | 175.00K | 180.00K | 150.00K | |||
| Other non cash items | 47.95M | 45.83M | 38.92M | 40.53M | -66.74M | |||
| OPERATING CASH FLOW | 7.61M | 7.02M | -1.95M | -65.99M | -26.72M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -39.98M | -41.06M | -28.75M | -30.89M | -64.14M | |||
| Other Investing Activity | 41.87M | 53.92M | 105.46M | 31.41M | -568.23M | |||
| INVESTING CASH FLOW | 1.89M | 12.86M | 76.71M | 520.00K | -632.37M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -70.00K | -760.00K | 331.36M | |||
| Stock Issued/Repurchased | 4.78M | 4.65M | 4.62M | 12.59M | 423.21M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | -29.29M | |||
| FINANCING CASH FLOW | 4.78M | 4.65M | 4.55M | 11.83M | 725.29M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 14.28M | 24.52M | 79.31M | -53.64M | 66.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 7.61M | 7.02M | -1.95M | -65.99M | -26.72M | |||
| Capital Expenditure | -39.98M | -41.06M | -28.75M | -30.89M | -64.14M | |||
| FREE CASH FLOW | -32.37M | -34.04M | -30.70M | -96.88M | -90.86M | |||
All data in USD